Literature DB >> 35178277

Use of Dexamethasone to Prevent Extubation Failure in Pediatric Intensive Care Unit: A Randomized Controlled Clinical Trial.

Haroldo Teófilo de Carvalho1, José Roberto Fioretto1, Rossano Cesar Bonatto1, Cristiane Franco Ribeiro1, Joelma Gonçalves Martin1, Mário Ferreira Carpi1.   

Abstract

Extubation failure is a common event in intensive care units. Corticosteroids are effective in preventing failure in adults, but no consensus has been reached on this matter in pediatrics. We assessed the efficacy of intravenous dexamethasone in mechanically ventilated children and adolescents for more than 48 hours, with at least one risk factor for failure. Extubations were scheduled 24 hours in advance when possible, and patients were randomly assigned into two groups: one group received a loading dose followed by up to four doses of dexamethasone, and the other group received no corticosteroids. Need for reintubation and length of stay in the pediatric intensive care unit were similar in both groups, and frequency of reintubation was 12.9%. Thieme. All rights reserved.

Entities:  

Keywords:  children; dexamethasone; extubation failure

Year:  2020        PMID: 35178277      PMCID: PMC8843376          DOI: 10.1055/s-0040-1719044

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  25 in total

1.  Comparison between noninvasive mechanical ventilation and standard oxygen therapy in children up to 3 years old with respiratory failure after extubation: a pilot prospective randomized clinical study.

Authors:  José R Fioretto; Cristiane F Ribeiro; Mario F Carpi; Rossano C Bonatto; Marcos A Moraes; Eduardo B Fioretto; Djalma J Fagundes
Journal:  Pediatr Crit Care Med       Date:  2015-02       Impact factor: 3.624

2.  Extubation failure in a large pediatric ICU population.

Authors:  S Edmunds; I Weiss; R Harrison
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

3.  Non-invasive ventilation on a pediatric intensive care unit: feasibility, efficacy, and predictors of success.

Authors:  Christian Dohna-Schwake; Florian Stehling; Eva Tschiedel; Michael Wallot; Uwe Mellies
Journal:  Pediatr Pulmonol       Date:  2011-05-26

4.  Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study.

Authors:  C R Westley; E K Cotton; J G Brooks
Journal:  Am J Dis Child       Date:  1978-05

Review 5.  Decision to extubate.

Authors:  S K Epstein
Journal:  Intensive Care Med       Date:  2002-04-12       Impact factor: 17.440

Review 6.  Prophylactic Corticosteroids for Prevention of Postextubation Stridor and Reintubation in Adults: A Systematic Review and Meta-analysis.

Authors:  Akira Kuriyama; Noriyuki Umakoshi; Rao Sun
Journal:  Chest       Date:  2017-02-21       Impact factor: 9.410

7.  Non invasive ventilation after extubation in paediatric patients: a preliminary study.

Authors:  Juan Mayordomo-Colunga; Alberto Medina; Corsino Rey; Andrés Concha; Sergio Menéndez; Marta Los Arcos; Irene García
Journal:  BMC Pediatr       Date:  2010-05-05       Impact factor: 2.125

8.  Assessment of respiratory drive and muscle function in the pediatric intensive care unit and prediction of extubation failure.

Authors:  T I Manczur; A Greenough; D Pryor; G F Rafferty
Journal:  Pediatr Crit Care Med       Date:  2000-10       Impact factor: 3.624

Review 9.  Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults.

Authors:  Robinder G Khemani; Adrienne Randolph; Barry Markovitz
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 10.  Design, analysis, and presentation of crossover trials.

Authors:  Edward J Mills; An-Wen Chan; Ping Wu; Andy Vail; Gordon H Guyatt; Douglas G Altman
Journal:  Trials       Date:  2009-04-30       Impact factor: 2.279

View more
  1 in total

1.  Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children.

Authors:  Laura Butragueño-Laiseca; Gema Manrique Martín; Rafael González Cortés; Corsino Rey Galán; Zuriñe Martínez de Compañón Martínez de Marigorta; Javier Gil Antón; Antonio Rodríguez Núñez; Cecilia M Fernández-Llamazares; Silvia Manrique-Rodríguez; Jesús López-Herce Cid
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.